SCHEMBL6980414

SCHEMBL6980414

N#Cc1ccc(CCC(=O)N2CCCc3cc(C(=O)N(c4ccccc4)c4ccccc4)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.44
TSHR P16473 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 3/20 0.42
NR3C1 P04150 1/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
MAPK1 P28482 2/20 0.40
RAB9A P51151 2/20 0.40
PARP1 P09874 1/20 0.40
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978699 0.91 POLB (0.48) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL6981025 0.90 MEN1 (0.57) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL7958428 0.89 MEN1 (0.46) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL6977395 0.87 TP53 (0.46) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL7960198 0.86 MEN1 (0.43) TP53TSHRMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL6985632 0.86 ITGB3 (0.41) TP53TSHRALDH1A1NPC1MAPT
SCHEMBL6986538 0.85 TP53 (0.49) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL7407025 0.85 NR3C1 (0.45) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL7948560 0.84 TP53 (0.43) TP53TSHRMEN1KMT2AALDH1A1
SCHEMBL6977738 0.84 TP53 (0.51) TP53TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed